Announcement on Convening Performance Briefing for 2025 and Q1 2026

About this update from Nanjing Well Pharmaceutical Group Co. Ltd. Class A

Announcement on Convening Performance Briefing for 2025 and Q1 2026 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Nanjing Well Pharmaceutical Group Co. Ltd. Class A